Cancer Control and Outcomes Program
The Cancer Control and Outcomes Program addresses a broad range of research questions along the cancer control continuum, which the National Cancer Institute defines as including cancer prevention, screening/early detection, diagnosis, treatment, and survivorship. This program contains four large scientific committees, by specialty (shown at right). Together, researchers in this program seek scientific advances along the continuum that can significantly reduce the burden of cancer on individual and societal levels.
This program is the centerpiece for the ECOG-ACRIN NCORP Research Base. Members of this Base use the rich resources of the Biomarker Sciences Program, with its laboratory sciences and imaging core facilities, and participate with the 12 cancer-type-oriented committees of the Therapeutic Studies Program to design and conduct treatment trials.
Thus, the Cancer Control and Outcomes Program is a critical and distinct part of the Group’s core mission and integrates Research Base scientific activities into ECOG-ACRIN's scientific culture. From this platform, therapeutic and translational discoveries in highly-focused clinical studies are broadened to larger diverse populations, are subject to rigorous analysis of patient benefit in terms of quality of life, and applied to earlier stages in the carcinogenesis process.
Program Co-Directors
Lynne I. Wagner, PhD
University of North Carolina-Chapel Hill and the UNC Lineberger Comprehensive Cancer Center
Biography
Community Advisory Committee
Chair
Co-Chair
Co-Chair
Kathleen J. Yost, MD
Cancer Research Consortium of West Michigan NCORP
Biography (to come)
Al B. Benson III, MD, FACP, FASCO
Northwestern University and the Robert H. Lurie Comprehensive Cancer Center
Biography
